Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Sep;37(9):1733–1736. doi: 10.1128/aac.37.9.1733

Treatment of Q fever.

D Raoult 1
PMCID: PMC188061  PMID: 8239576

Full text

PDF
1733

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Applefeld M. M., Billingsley L. M., Tucker H. J., Fiset P. Q fever endocarditis--a case occurring in the United States. Am Heart J. 1977 May;93(5):669–670. [PubMed] [Google Scholar]
  2. Bertrand A., Janbon F., Jonquet O., Reynes J. Infections par les rickettsiales et fluoroquinolones. Pathol Biol (Paris) 1988 May;36(5):493–495. [PubMed] [Google Scholar]
  3. Brouqui P., Dupont H. T., Drancourt M., Berland Y., Etienne J., Leport C., Goldstein F., Massip P., Micoud M., Bertrand A. Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med. 1993 Mar 8;153(5):642–648. doi: 10.1001/archinte.153.5.642. [DOI] [PubMed] [Google Scholar]
  4. Drancourt M., Raoult D., Xeridat B., Milandre L., Nesri M., Dano P. Q fever meningoencephalitis in five patients. Eur J Epidemiol. 1991 Mar;7(2):134–138. doi: 10.1007/BF00237356. [DOI] [PubMed] [Google Scholar]
  5. Dupuis G., Péter O., Pedroni D., Petite J. Aspects cliniques observés lors d'une épidémie de 415 cas de fièvre Q. Schweiz Med Wochenschr. 1985 Jun 15;115(24):814–818. [PubMed] [Google Scholar]
  6. Ellis M. E., Smith C. C., Moffat M. A. Chronic or fatal Q-fever infection: a review of 16 patients seen in North-East Scotland (1967-80). Q J Med. 1983 Winter;52(205):54–66. [PubMed] [Google Scholar]
  7. Fernández-Guerrero M. L., Muelas J. M., Aguado J. M., Renedo G., Fraile J., Soriano F., De Villalobos E. Q fever endocarditis on porcine bioprosthetic valves. Clinicopathologic features and microbiologic findings in three patients treated with doxycycline, cotrimoxazole, and valve replacement. Ann Intern Med. 1988 Feb;108(2):209–213. doi: 10.7326/0003-4819-108-2-209. [DOI] [PubMed] [Google Scholar]
  8. Freeman R., Hodson M. E. Q fever endocarditis treated with trimethoprim and sulphamethoxazole. Br Med J. 1972 Feb 12;1(5797):419–420. doi: 10.1136/bmj.1.5797.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HUEBNER R. J., HOTTLE G. A., ROBINSON E. B. Action of streptomycin in experimental infection with Q fever. Public Health Rep. 1948 Mar 19;63(12):357–362. [PMC free article] [PubMed] [Google Scholar]
  10. Hackstadt T., Williams J. C. Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc Natl Acad Sci U S A. 1981 May;78(5):3240–3244. doi: 10.1073/pnas.78.5.3240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Haldane E. V., Marrie T. J., Faulkner R. S., Lee S. H., Cooper J. H., MacPherson D. D., Montague T. J. Endocarditis due to Q fever in Nova Scotia: experience with five patients in 1981-1982. J Infect Dis. 1983 Dec;148(6):978–985. doi: 10.1093/infdis/148.6.978. [DOI] [PubMed] [Google Scholar]
  12. Jabarit-Aldighieri N., Torres H., Raoult D. Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin. Antimicrob Agents Chemother. 1992 Nov;36(11):2529–2532. doi: 10.1128/aac.36.11.2529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Levy P. Y., Drancourt M., Etienne J., Auvergnat J. C., Beytout J., Sainty J. M., Goldstein F., Raoult D. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob Agents Chemother. 1991 Mar;35(3):533–537. doi: 10.1128/aac.35.3.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Levy P., Raoult D., Razongles J. J. Q-fever and autoimmunity. Eur J Epidemiol. 1989 Dec;5(4):447–453. doi: 10.1007/BF00140139. [DOI] [PubMed] [Google Scholar]
  15. Mallavia L. P. Genetics of rickettsiae. Eur J Epidemiol. 1991 May;7(3):213–221. doi: 10.1007/BF00145669. [DOI] [PubMed] [Google Scholar]
  16. Maurin M., Benoliel A. M., Bongrand P., Raoult D. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J Infect Dis. 1992 Nov;166(5):1097–1102. doi: 10.1093/infdis/166.5.1097. [DOI] [PubMed] [Google Scholar]
  17. McCaul T. F., Williams J. C. Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol. 1981 Sep;147(3):1063–1076. doi: 10.1128/jb.147.3.1063-1076.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. POWELL O. W., KENNEDY K. P., McIVER M., SILVERSTONE H. Tetracycline in the treatment of "Q" fever. Australas Ann Med. 1962 Aug;11:184–188. doi: 10.1111/imj.1962.11.3.184. [DOI] [PubMed] [Google Scholar]
  19. Peacock M. G., Philip R. N., Williams J. C., Faulkner R. S. Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis. Infect Immun. 1983 Sep;41(3):1089–1098. doi: 10.1128/iai.41.3.1089-1098.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pérez-del-Molino A., Aguado J. M., Riancho J. A., Sampedro I., Matorras P., Gonzalez-Macias J. Erythromycin and the treatment of Coxiella burnetii pneumonia. J Antimicrob Chemother. 1991 Sep;28(3):455–459. doi: 10.1093/jac/28.3.455. [DOI] [PubMed] [Google Scholar]
  21. ROBSON A. O., SHIMMIN C. D. Chronic Q fever. I. Clinical aspects of a patient with endocarditis. Br Med J. 1959 Nov 14;2(5158):980–983. doi: 10.1136/bmj.2.5158.980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Raoult D., Bres P., Drancourt M., Vestris G. In vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin. Antimicrob Agents Chemother. 1991 Jan;35(1):88–91. doi: 10.1128/aac.35.1.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Raoult D., Drancourt M., Vestris G. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob Agents Chemother. 1990 Aug;34(8):1512–1514. doi: 10.1128/aac.34.8.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Raoult D., Torres H., Drancourt M. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob Agents Chemother. 1991 Oct;35(10):2070–2077. doi: 10.1128/aac.35.10.2070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Raoult D., Urvölgyi J., Etienne J., Roturier M., Puel J., Chaudet H. Diagnosis of endocarditis in acute Q-fever by immunofluorescence serology. Acta Virol. 1988 Jan;32(1):70–74. [PubMed] [Google Scholar]
  26. Raoult D., Yeaman M. R., Baca O. G. Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells. Antimicrob Agents Chemother. 1989 May;33(5):621–623. doi: 10.1128/aac.33.5.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ross P. J., JacobsoJn J., Muir J. R. Q fever endocarditis of porcine xenograft valves. Am Heart J. 1983 Jan;105(1):151–153. doi: 10.1016/0002-8703(83)90293-4. [DOI] [PubMed] [Google Scholar]
  28. STOKER M. G., FISET P. Phase variation of the Nine Mile and other strains of Rickettsia burneti. Can J Microbiol. 1956 May;2(3):310–321. doi: 10.1139/m56-036. [DOI] [PubMed] [Google Scholar]
  29. Spelman D. W. Q fever: a study of 111 consecutive cases. Med J Aust. 1982 Jun 26;1(13):547-8, 551, 553. doi: 10.5694/j.1326-5377.1982.tb124169.x. [DOI] [PubMed] [Google Scholar]
  30. Subramanya N. I., Wright J. S., Khan M. A. Failure of rifampicin and co-trimoxazole in Q fever endocarditis. Br Med J (Clin Res Ed) 1982 Jul 31;285(6338):343–344. doi: 10.1136/bmj.285.6338.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tissot Dupont H., Raoult D., Brouqui P., Janbon F., Peyramond D., Weiller P. J., Chicheportiche C., Nezri M., Poirier R. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med. 1992 Oct;93(4):427–434. doi: 10.1016/0002-9343(92)90173-9. [DOI] [PubMed] [Google Scholar]
  32. Tobin M. J., Cahill N., Gearty G., Maurer B., Blake S., Daly K., Hone R. Q fever endocarditis. Am J Med. 1982 Mar;72(3):396–400. doi: 10.1016/0002-9343(82)90495-8. [DOI] [PubMed] [Google Scholar]
  33. Torres H., Raoult D. In vitro activities of ceftriaxone and fusidic acid against 13 isolates of Coxiella burnetii, determined using the shell vial assay. Antimicrob Agents Chemother. 1993 Mar;37(3):491–494. doi: 10.1128/aac.37.3.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tunstall Pedoe H. D. Apparent recurrence of Q fever endocarditis following homograft replacement of aortic valve. Br Heart J. 1970 Jul;32(4):568–570. doi: 10.1136/hrt.32.4.568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Turck W. P., Howitt G., Turnberg L. A., Fox H., Longson M., Matthews M. B., Das Gupta R. Chronic Q fever. Q J Med. 1976 Apr;45(178):193–217. [PubMed] [Google Scholar]
  36. Turck W. P., Matthews M. B. Rickettsial endocarditis. Br Med J. 1969 Jan 18;1(5637):185–186. doi: 10.1136/bmj.1.5637.185-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Varma M. P., Adgey A. A., Connolly J. H. Chronic Q fever endocarditis. Br Heart J. 1980 Jun;43(6):695–699. doi: 10.1136/hrt.43.6.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wilson H. G., Neilson G. H., Galea E. G., Stafford G., O'Brien M. F. Q fever endocarditis in Queensland. Circulation. 1976 Apr;53(4):680–684. doi: 10.1161/01.cir.53.4.680. [DOI] [PubMed] [Google Scholar]
  39. Yeaman M. R., Baca O. G. Unexpected antibiotic susceptibility of a chronic isolate of Coxiella burnetii. Ann N Y Acad Sci. 1990;590:297–305. doi: 10.1111/j.1749-6632.1990.tb42236.x. [DOI] [PubMed] [Google Scholar]
  40. Yeaman M. R., Mitscher L. A., Baca O. G. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob Agents Chemother. 1987 Jul;31(7):1079–1084. doi: 10.1128/aac.31.7.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Yeaman M. R., Roman M. J., Baca O. G. Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes. Antimicrob Agents Chemother. 1989 Jul;33(7):1052–1057. doi: 10.1128/aac.33.7.1052. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES